Careers  |  Sign In  |  Register

Latest in Oncology

Recent trials from Celldex Therapeutics Inc have demonstrated the potential of their new vaccine, Rintega, in treating patients with glioblastoma multiforme (GBM) by utilizing the immune system in conjunction with other drugs, reports Reuters. Of the 73 patients with the recurrent malignant tumor, thirty...
AstraZeneca and Eli Lilly have announced plans to combine two cancer drugs--one experimental and one previously approved--in clinical trials to test the efficacy against solid tumors, according to Reuters. The new drug is designed as  immune system support while the older drug is an antiangiogenic...
According to The New York Times, the FBI has launched an investigation into the use of morcellators in hysterectomies and whether harmful effects from its use were ignored. Typically, the use of this tool helps make surgeries safer and less invasive, yet if there are undetected cancers in the uterus, the...